ABPHARM ANALYTICAL CONSULTANCY LIMITED
Significant control: Alan Banyard (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Abpharm Analytical Consultancy Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Abpharm Analytical Consultancy Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ABPHARM ANALYTICAL CONSULTANCY LIMITED is an active private limited company (company number 07964279) incorporated on 24 February 2012, registered in Thame. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 March 2026, showing net assets of £492k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 10% on the prior period (£449k).
By net assets it sits in the top quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
Ownership and control
- Mr Alan Banyard
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 24 February 201214 yrs ago
- Next accounts due
- 31 December 2027in 431 days
- Confirmation statement due
- 10 March 2027in 135 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2026 | £492k | — | — | — | — | — | 2 |
| 31 March 2025 | £449k | — | — | — | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £492,047 at 31 March 2026
- Incorporated five or more years agoIncorporated 24 February 2012
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 431 days
- Confirmation statement duein 135 days
- Accounts period endNet assets £492k · micro accounts
- Accounts period endNet assets £449k · micro accounts
- Incorporated
Similar companies in Oxford
- OXFORD VACMEDIX UK LIMITEDOxford · inc. Mar 2012
- ALCHEMY PHARMATECH LIMITEDWatlington · inc. Jan 2012
- INVIVUSBIO LIMITEDOxford · inc. May 2012
- LUCILIA PHARMA LIMITEDWitney · inc. Jul 2012
- PERSPECTUM LTDOxford · inc. Sept 2012
- NAVIDEA BIOPHARMACEUTICALS LIMITEDThame · inc. Jul 2011
All companies incorporated on 24 February 2012 · in Feb 2012.
Reminders for ABPHARM ANALYTICAL CONSULTANCY LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.